A. Kolk et al., ACUTE LETHAL NECROTIZING PANCREATITIS IN CHILDHOOD SYSTEMIC LUPUS-ERYTHEMATOSUS - POSSIBLE TOXICITY OF IMMUNOSUPPRESSIVE THERAPY, Clinical and experimental rheumatology, 13(3), 1995, pp. 399-403
We report on a 16 year old girl with a three-year history of systemic
lupus erythematosus who developed a case of acute lethal haemorrhagic
pancrentitis. She presented with high grade fever, skirt rash malaise,
and arthralgias. Laboratory lupus activity parameters were markedly e
levated. In the absence of renal, pulmonary, cardiac or cerebral invol
vement, our patient developed pancreatitis leading to pancreatogenic s
hock. Until 14 days before the onset of pancreatitis, the patient's me
dications included prednisolone, azathioprine and methotrexate. At aut
opsy, no autoimmune vasculitis was found in the affected pancreatic ti
ssue. Therefor-e, an etiologic role of combination therapy had to be c
onsidered. Whereas methotrexate has never been reported to be linked t
o pancreatitis, a few publications describing prednisolone and azathio
prine in connection with pancreatitis do exist. Thus, if pancreatitis
is not just termed idiopathic, it must be attributed to a combination
regimen of drugs including methotrexate. A review of the literature sh
ows that pancreatitis in SLE is rare and has never been associated wit
h methotrexate therapy before.